- Conditions
- Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +34 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- AdventHealth Orlando Orlando, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Clinical trial condition
Myelodysplastic Syndrome With Excess Blasts
Explore clinical trials studying Myelodysplastic Syndrome With Excess Blasts. Study availability and eligibility vary by location and protocol.
15 public trials
7 recruiting studies
Myelodysplastic Syndrome With Excess Blasts trial results
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
NCT05600894
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCI Health Laguna Hills Laguna Hills, California, United States
Active, Not Recruiting
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
NCT03399773
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Anemia, +29 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT01522976
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
NCT00392353
- Conditions
- Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- North Shore University Hospital Manhasset, New York, United States
- Mount Sinai Hospital New York, United States